Novel multifunctional theranostic liposome drug delivery system: Construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging

Bioconjugate Chemistry

Volumn 23, Issue 6, 2012, Pages 1322-1332

  Li, Shihong ^a   Goins, Beth ^a   Zhang, Lujun ^a   Bao, Ande ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; DIAGNOSIS; FLUORESCENCE IMAGING; INFRARED DEVICES; MAGNETIC RESONANCE IMAGING; NITROGEN COMPOUNDS; PARTICLE BEAMS; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY;

DOXORUBICIN; DRUG-DELIVERY SYSTEMS; FLUORESCENT IMAGING; LIPID NANOPARTICLES; MULTI-MODALITY; NEAR-INFRARED FLUORESCENT; NUCLEAR IMAGING; SYSTEM CONSTRUCTION; THERANOSTICS; TOMOGRAPHY IMAGING;

LIPOSOMES;

AMMONIUM SULFATE; CHOLESTEROL; COPPER 64; DOXORUBICIN; FLUORESCENT DYE; GADOTERIC ACID; LIPOSOME; TECHNETIUM 99M; TETRACYCLINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DISTRIBUTION; DRUG RETENTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IMAGE ANALYSIS; IN VIVO STUDY; ISOTOPE LABELING; LIPOSOMAL DELIVERY; MULTIFUNCTIONAL THERANOSTIC LIPOSOME DRUG DELIVERY SYSTEM; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PH; POSITRON EMISSION TOMOGRAPHY; PROCESS DEVELOPMENT; RAT; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEM ANALYSIS; TUMOR XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COPPER RADIOISOTOPES; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HEAD AND NECK NEOPLASMS; HETEROCYCLIC COMPOUNDS; LIPOSOMES; MALE; OPTICAL IMAGING; ORGANOMETALLIC COMPOUNDS; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, NUDE; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84862644348     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300175d     Document Type: Article

References (60)

1. Khullar, O., Frangioni, J. V., Grinstaff, M., and Colson, Y. L. (2009) Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. Semin. Thorac. Cardiovasc. Surg. 21, 309-315.
2. Troyan, S. L., Kianzad, V., Gibbs-Strauss, S. L., Gioux, S., Matsui, A., Oketokoun, R., Ngo, L., Khamene, A., Azar, F., and Frangioni, J. V. (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann. Surg. Oncol. 16, 2943-2952.
3. Moser, E., Stadlbauer, A., Windischberger, C., Quick, H. H., and Ladd, M. E. (2009) Magnetic resonance imaging methodology. Eur. J. Nucl. Med. Mol. Imaging 36 (Suppl 1), S30-S41.
4. Lanza, G. M., Winter, P. M., Caruthers, S. D., Morawski, A. M., Schmieder, A. H., Crowder, K. C., and Wickline, S. A. (2004) Magnetic resonance molecular imaging with nanoparticles. J. Nucl. Cardiol. 11, 733-743.
5. Blasberg, R. G., and Gelovani, J. (2002) Molecular-genetic imaging: A nuclear medicine-based perspective. Mol. Imaging 1, 280-300.
6. Margolis, D. J. A., Hoffman, J. M., Herfkens, R. J., Jeffrey, R. B., Quon, A., and Gambhir, S. S. (2007) Molecular imaging techniques in body imaging. Radiology 245, 333-356.
7. Koning, G. A., and Krijger, G. C. (2007) Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Anticancer Agents Med. Chem. 7, 425-440.
8. Jennings, L. E., and Long, N. J. (2009) 'Two is better than one' - probes for dual-modality molecular imaging. Chem. Commun. (Camb.) 24, 3511-3524.
9. Martí-Bonmatí, L., Sopena, R., Bartumeus, P., and Sopena, P. (2010) Multimodality imaging techniques. Contrast Media Mol. Imaging 5, 180-189.
10. Louie, A. (2010) Multimodality imaging probes: design and challenges. Chem. Rev. 110, 3146-3195.
11. Buse, J., and El-Aneed, A. (2010) Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances. Nanomedicine 5, 1237-1260.
12. Lammers, T., Kiessling, F., Hennink, W. E., and Storm, G. (2010) Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol. Pharmaceutics 7, 1899-1912.
13. Gabizon, A. (2007) Applications of liposomal drug delivery systems to cancer therapy. In Nanotechnology for Cancer Therapy (Amiji, M. M., Ed.) pp 595-611, CRC Press, Boca Raton.
14. Elbayoumi, T. A., and Torchilin, V. P. (2010) Current trends in liposome research. Methods Mol. Biol. 605, 1-27.
15. Farokhzad, O., and Langer, R. (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug Delivery Rev. 58, 1456-1459.
16. Puri, A., Loomis, K., Smith, B., Lee, J. H., Yavlovich, A., Heldman, E., and Blumenthal, R. (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit. Rev. Ther. Drug Carrier Syst. 26, 523-580.
17. 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies. J. Pharmacol. Exp. Ther. 308, 419-425.
18. 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats. J. Nucl. Med. 44, 1992-1999.
19. Cullis, P. R., Hope, M. J., Bally, M. B., Madden, T. D., Mayer, L. D., and Fenske, D. B. (1997) Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta 1331, 187-211.
20. 188Re).
21. Hak, S., Sanders, H. M., Agrawal, P., Langereis, S., Grüll, H., Keizer, H. M., Arena, F., Terreno, E., Strijkers, G. J., and Nicolay, K. (2009) A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging. Eur. J. Pharm. Biopharm. 72, 397-404.
22. Oliver, M., Ahmed, A., Kamaly, N., Perouzel, E., Caussin, A., Keller, M., Herlihy, A., Bell, J., Miller, A. D., and Jorgensen, M. R. (2006) MAGfect: a novel liposome formulation for MRI labeling and visualization of cells. Org. Biomol. Chem. 4, 3489-3497.
23. Mulder, W. J. M., Strijkers, G. J., van Tilborg, G. A. F., Griffioen, A. W., and Nicolay, K. (2006) Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 19, 142-164.
24. Mulder, W. J., van der Schaft, D. W., Hautvast, P. A., Strijkers, G. J., Koning, G. A., Storm, G., Mayo, K. H., Griffioen, A. W., and Nicolay, K. (2007) Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J. 21, 378-383.
25. Harrington, K. J., Rowlinson-Busza, G., Syrigos, K. N., Uster, P. S., Vile, R. G., and Stewart, J. S. (2000) Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Clin. Cancer Res. 6, 2528-2537.
26. Bao, A., Phillips, W. T., Goins, B., Zheng, X., Sabour, S., Natarajan, M., Woolley, F. R., Zavaleta, C., and Otto, R. A. (2006) Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection. Int. J. Pharm. 316, 162-169.
27. French, J. T., Goins, B., Phillips, W. T., Saenz, M., Li, S., Garcia- Rojas, X., Otto, R. A., and Bao, A. (2010) Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium-186 radionuclide. J. Vasc. Interven. Radiology 21, 1271-1279.
28. 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model. Clin. Cancer Res. 14, 3975-3983.
29. 186Re radionuclides. Phys. Med. Biol. 56, 5721-5734.
30. Luboldt, W., Pinkert, J., Matzky, C., Wunderlich, G., and Kotzerke, J. (2009) Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics. Curr. Drug Delivery 6, 255-260.
31. Allard, E., Passirani, C., and Benoit, J. P. (2009) Convectionenhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials 30, 2302-2318.
32. Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., and Li, S. D. (2011) MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials 32, 6570-6578.
33. Hermanson, G. T. (1996) Bioconjugate Techniques, pp 139-140 and 173-176, Academic Press - An Imprint of Elsevier, San Diego, CA.
34. Uster, P. S., Allen, T. M., Daniel, B. E., Mendez, C. J., Newman, M. S., and Zhu, G. Z. (1996) Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. 386, 243-246.
35. Allen, T. M., Sapra, P., and Moase, E. (2002) Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell. Mol. Biol. Lett. 7, 889-894.
36. Moreira, J. N., Ishida, T., Gaspar, R., and Allen, T. M. (2002) Use of the post-insertion technique to insert peptide ligands into preformed stealth liposomes with retention of binding activity and cytotoxicity. Pharm. Res. 19, 265-269.
37. Goins, B., Bao, A., and Phillips, W. T. (2010) Techniques for loading technetium-99m and rhenium-186/188 radionuclides into preformed liposomes for diagnostic imaging and radionuclide therapy. Methods Mol. Biol. 606, 469-491.
38. Li, S., Goins, B., Phillips, W. T., and Bao, A. (2011) Remote-loading labeling of liposomes with 99mTc-BMEDA and its stability evaluation: effects of lipid formulation and pH/chemical gradient. J. Liposome Res. 21, 17-27.
39. Bao, A., Phillips, W. T., Goins, B., McGuff, H. S., Zheng, X., Woolley, F. R., Natarajan, M., Santoyo, C., Miller, F. R., and Otto, R. A. (2006) Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats. Otolaryngol. Head Neck Surg. 135, 583-587.
40. Gabizon, A., Shmeeda, H., and Barenholz, Y. (2003) Pharmacokinetics of pegylated liposomal doxorubicin: Review of animal and human studies. Clin. Pharmacokinet. 42, 419-436.
41. Fenske, D. B., and Cullis, P. R. (2005) Entrapment of small molecules and nucleic acid-based drugs in liposomes. Methods Enzymol. 391, 7-40.
42. Marshall, M. V., Draney, D., Sevick-Muraca, E. M., and Olive, D. M. (2010) Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol. Imaging Biol. 12, 583-594.
43. Krauze, M. T., Forsayeth, J., Park, J. W., and Bankiewicz, K. S. (2006) Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res. 23, 2493-2504.
44. Hossann, M., Wang, T., Wiggenhorn, M., Schmidt, R., Zengerle, A., Winter, G., Eibl, H., Peller, M., Reiser, M., Issels, R. D., and Lindner, L. H. (2010) Size of thermosensitive liposomes influences content release. J. Controlled Release 147, 436-443.
45. Grange, C., Geninatti-Crich, S., Esposito, G., Alberti, D., Tei, L., Bussolati, B., Aime, S., and Camussi, G. (2010) Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin- containing liposomes in experimentally induced Kaposi's sarcoma. Cancer Res. 70, 2180-2190.
46. De Smet, M., Heijman, E., Langereis, S., Hijnen, N. M., and Grüll, H. (2011) Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. J. Controlled Release 150, 102-110.
47. Trubetskoy, V. S., Cannillo, J. A., Milshtein, A., Wolf, G. L., and Torchilin, V. P. (1995) Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magn. Reson. Imaging 13, 31-37.
48. Weissig, V. V., Babich, J., and Torchilin, V. V. (2000) Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. Colloids Surf., B: Biointerfaces 18, 293-299.
49. Bui, T., Stevenson, J., Hoekman, J., Zhang, S., Maravilla, K., and Ho, R. J. (2010) Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging. PLoS One 5, pii: e13082.
50. Viglianti, B. L., Abraham, S. A., Michelich, C. R., Yarmolenko, P. S., MacFall, J. R., Bally, M. B., and Dewhirst, M. W. (2004) In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn. Reson. Med. 51, 1153-1162.
51. Viglianti, B. L., Ponce, A. M., Michelich, C. R., Yu, D., Abraham, S. A., Sanders, L., Yarmolenko, P. S., Schroeder, T., MacFall, J. R., Barboriak, D. P., Colvin, O. M., Bally, M. B., and Dewhirst, M. W. (2006) Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn. Reson. Med. 56, 1011-1018.
52. Ponce, A. M., Viglianti, B. L., Yu, D., Yarmolenko, P. S., Michelich, C. R., Woo, J., Bally, M. B., and Dewhirst, M. W. (2007) Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J. Natl. Cancer Inst. 99, 53-63.
53. Silva, A. C., Lee, J. H., Aoki, I., and Koretsky, A. P. (2004) Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed. 17, 532-543.
54. Morcos, S. K. (2008) Extracellular gadolinium contrast agents: differences in stability. Eur. J. Radiol. 66, 175-179.
55. 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials 32, 2334-2341.
56. 64Cu for positron emission tomography (PET) imaging. Bioconjugate Chem. 19, 2577-2584.
57. 64Cu for positron emission tomography imaging. Bioconjugate Chem. 22, 808-818.
58. Uusijärvi, H., Bernhardt, P., Rösch, F., Maecke, H. R., and Forssell-Aronsson, E. (2006) Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production. J. Nucl. Med. 47, 807-814.
59. Howell, R. W., Rao, D. V., and Sastry, K. S. (1989) Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumours. Med. Phys. 16, 66-74.
60. Novak-Hofer, I., and Schubiger, P. A. (2002) Copper-67 as a therapeutic nuclide for radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imaging 29, 821-830.